GlassScriptPhysician profile
Ian Reynolds
NPI 1184804312
$1,310.13
in general payments reported to CMS, 2019-2025
15 companies · $591 in 2025
The $591 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.30 · 2020: $95.55 · 2021: $29.56 · 2022: $422 · 2023: $74.69 · 2024: $25.60 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $371.23 | 2020-2025 | |
| Vgi Medical, LLC | $201.81 | 2022 | |
| Xtant Medical INC | $149.36 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $97.46 | 2024-2025 | |
| Shalby Advanced Technologies, INC. | $80.45 | 2022 | |
| Pacira Therapeutics, INC. | $72.30 | 2019 | |
| Intrinsic Therapeutics | $60.73 | 2022 | |
| Si-Bone, INC. | $58.48 | 2022 | |
| Horizon Therapeutics Plc | $51.74 | 2020-2023 | Krystexxa |
| Wenzel Spine, INC. | $40.65 | 2023-2025 | Profile, Varilift |
| Endo Pharmaceuticals INC. | $35.88 | 2020-2021 | |
| Bioventus LLC | $31.26 | 2020 | |
| Treace Medical Concepts, INC. | $26.19 | 2025 | |
| Surgalign Spine Technologies, INC. | $20.16 | 2022 | |
| Anika Therapeutics, INC. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.